Regulatory Approval Delays and Failures: ESTA operates in a highly regulated industry, and delays or failures in obtaining or maintaining necessary regulatory approvals (e.g., FDA, CE Mark) for its products in key markets could significantly impede its ability to commercialize or continue selling its devices.

Product Liability Exposure: As a manufacturer of implantable medical devices, ESTA faces inherent risks of product liability claims if its products are alleged to cause injury or adverse events. Successful claims could result in substantial damages, reputational harm, and increased insurance costs.

Intense Market Competition: The breast aesthetics market is competitive, with established players and new entrants. ESTA's ability to maintain or grow market share is challenged by competitors' pricing strategies, technological advancements, and marketing efforts, potentially impacting revenue and profitability.